Endovalpin en es it fr

Endovalpin Brand names, Endovalpin Analogs

Endovalpin Brand Names Mixture

  • No information avaliable

Endovalpin Chemical_Formula


Endovalpin RX_link

No information avaliable

Endovalpin fda sheet

Endovalpin msds (material safety sheet)

Endovalpin Synthesis Reference

No information avaliable

Endovalpin Molecular Weight

362.346 g/mol

Endovalpin Melting Point

329 oC

Endovalpin H2O Solubility

1600 mg/L

Endovalpin State


Endovalpin LogP


Endovalpin Dosage Forms

Tablet (oral, 50mg)

Endovalpin Indication

For use in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcer, to reduce further gastric acid secretion and delay gastric emptying.

Endovalpin Pharmacology

Anisotropine methylbromide is a quaternary ammonium compound. Its use as treatment adjunct in peptic ulcer has been replaced by the use of more effective agents. Depending on the dose, anisotropine methylbromide may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder. In general, smaller doses of anisotropine methylbromide inhibit salivary and bronchial secretions, sweating, and accommodation; cause dilatation of the pupil; and increase the heart rate. Larger doses are required to decrease motility of the gastrointestinal and urinary tracts and to inhibit gastric acid secretion.

Endovalpin Absorption

Gastrointestinal absorption is poor and irregular. Total absorption after an oral dose is about 10 to 25%.

Endovalpin side effects and Toxicity

No information avaliable

Endovalpin Patient Information

Endovalpin Organisms Affected

Humans and other mammals